INITIAL RESULTS FROM A FIRST-IN-HUMAN STUDY OF IMGN779, A CD33-TARGETING ANTIBODY-DRUG CONJUGATE (ADC) WITH NOVEL DNA ALKYLATING ACTIVITY, IN PATIENTS WITH RELAPSED OR REFRACTORY AML

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Cortes, J; DeAngelo, D; Wang, E; Arana-Yi, C; Zweidler-McKay, P; Munteanu, M; Andreu-Vieyra, C; Erba, H; Blum, W; Traer, E

Published Date

  • June 26, 2017

Published In

Volume / Issue

  • 102 /

Start / End Page

  • 217 - 218

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0390-6078

Conference Name

  • 22nd Congress of the European-Hematology-Association

Conference Location

  • Madrid, SPAIN

Conference Start Date

  • June 22, 2017

Conference End Date

  • June 25, 2017